DaVita Inc
NYSE:DVA
DaVita Inc
NYSE:DVA
Price:
134.45 USD
-5.48%
Market Closed
Updated:
May 6, 2024
DaVita Inc
Revenue
|
DaVita Inc
Revenue Peer Comparison
Comparables:
CHE
DGX
CVS
CI
LH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Chemed Corp
NYSE:CHE
|
Revenue
$2.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$360.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
DaVita Inc
Revenue Breakdown
Breakdown by Geography
DaVita Inc
DaVita Inc
Not Available
Breakdown by Segments
DaVita Inc
DaVita Inc
|
Total Revenue:
12.1B
USD
|
|
United States Dialysis:
10.8B
USD
|
|
Other - Ancillary Services:
1.3B
USD
|
See Also
What is DaVita Inc's Revenue?
Revenue
12.1B
USD
12.1B
USD
Based on the financial report for Dec 31, 2023, DaVita Inc's Revenue amounts to 12.1B USD.
What is DaVita Inc's Revenue growth rate?
Revenue CAGR 10Y
0%
0%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for DaVita Inc have been 2% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
